1
|
Alkhayat N, Alshahrani M, Elyamany G, Sedick Q, Ibrahim W, Hamzi H, Binhassan A, Othman M, Alshieban S, Aljabry MS, Asiri S, Alzouman M, Alsuhaibani O, Alabbas F, Alsharif O, Elborai Y. Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia. J Egypt Natl Canc Inst 2021; 33:21. [PMID: 34396456 DOI: 10.1186/s43046-021-00078-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2020] [Accepted: 07/18/2021] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Hodgkin lymphoma (HL) is lymphoid neoplasm usually affecting lymphatic system; it accounts 3.6% of cancers in Saudi Arabia. Modern treatment protocols had shown particular success rates in overall-survival (OS) and event-free-survival (EFS). In our study, we reviewed the medical records of 80 pediatric and young adolescent patients diagnosed HL from January 2006 to July 2020, treated at tertiary care hospital in Riyadh, Saudi Arabia. Demographic, clinical, and pathological data were explored. First line therapy was ABVD, COG, COPP, R-CHOP, or radiotherapy alone in 53/80 (66.4%), 24/80 (30%), 1/80 (1.2%), 1/80 (1.2%), or 1/80 (1.2%) patients; respectively. Response assessment was done by CT + / - PET scan after first 2 cycles then every 2 cycle and end of therapy. Another assessment was done if any clinical suspicion of recurrence. RESULTS Median age 11 (range 3-16) years. Males to females 1.3:1. Seventy-two out of eighty (90%) patients showed first complete remission (CR1) and maintained remission for median 40 (range 7-136) months. Eight out of eighty (10%) patients showed refractory disease. Nineteen patients received salvage therapy (ICE or ESHAP/brentuximab vedotin or gemcitabine/brentuximab vedotin), 14/19 (73.7%) had 2nd complete remission (CR2) for median time 24 (ranged 9-78) months, while 5/19 (26.3%) did not show any response. Five-year OS and EFS were 95% and 75%. Two patients had 2ry malignant neoplasms, one had AML and died, the other had malignant fibrous histocytoma and still alive. None of our patients had fertility problem. Also, they did not experience chronic pulmonary or cardiotoxicity. Classic Hodgkin's lymphoma: nodular sclerosis subtype was more prominent (55%) than mixed cellularity subtype (22.5%), which is similar to several European and US studies, lymphocyte rich (11.25%) and lymphocyte depleted (0%), while nodular lymphocyte predominant Hodgkin's lymphoma (11.25%). CONCLUSIONS Our study provided unique descriptive study of childhood HL, in Saudi Arabia, with valuable insight into the long-term outcome and late toxicity. Our results are comparable to other studies in the Middle East and European countries.
Collapse
Affiliation(s)
- Nawaf Alkhayat
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Mohammad Alshahrani
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia.
| | - Ghaleb Elyamany
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Qanita Sedick
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Walid Ibrahim
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Hasna Hamzi
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Amal Binhassan
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Mohamed Othman
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Saeed Alshieban
- Department of Pathology and Laboratory Medicine, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
| | - Mansour S Aljabry
- Pathology Department, King Khalid University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia
| | - Shuaa Asiri
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Muneerah Alzouman
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Omar Alsuhaibani
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Fahad Alabbas
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Omar Alsharif
- Department of Pediatric Hematology/Oncology, Prince Sultan Military Medical City, Riyadh, Riyadh, 11159, Saudi Arabia
| | - Yasser Elborai
- Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
| |
Collapse
|
2
|
Alabbas F, Elyamany G, Alkhayat N, AlShahrani M, Ibrahim W, Elborai Y, Binhassan A, Hamzi H, Al Thibani N, Alakel S, Alsharif F, Alsuhaibani O, Alsharif O. Assessment of Health-related Quality of Life in Saudi Children with Cancer. Health Serv Insights 2021; 14:11786329211029351. [PMID: 34285506 PMCID: PMC8264724 DOI: 10.1177/11786329211029351] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2020] [Accepted: 06/07/2021] [Indexed: 11/15/2022] Open
Abstract
Advances in pediatric cancer treatment and dramatic improvement in long-term survival have made health-related quality of life (HRQOL) a priority. This study describes the HRQOL of Saudi children on cancer treatment, given the paucity of data on the subject. Parents of children undergoing cancer treatment between the ages of 2 and 12 years enrolled to answer the Arabic version of the parent proxy report PedsQL™ 3.0 cancer module. The module items were reverse-scored to a linear scale from 0 to 100, in which higher scores indicated a better HRQOL. Of the 95 study participants, 61 (64.2%) were hematological malignancies and 34 (35.8%) solid malignancies. The mean score of our sample's total HRQOL was 72.3, which is in line with the results of similar studies worldwide. The lowest scores were observed for procedural anxiety (60.14), perceived physical appearance (67.37), and treatment anxiety (67.58), while the highest were for communication (80.21), nausea (78.32), and cognitive problems (78.32). Significant associations were reported between the patients aged younger than 5 years and procedural anxiety, those aged 5 years or older and perceived physical appearance, and frequent hospital visits and worry. Healthcare professionals should consider the poor HRQOL sub-scales and their associated risks to improve treatment outcomes.
Collapse
Affiliation(s)
- Fahad Alabbas
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Ghaleb Elyamany
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Nawaf Alkhayat
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Mohammad AlShahrani
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Walid Ibrahim
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Yasser Elborai
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.,Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
| | - Amal Binhassan
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Hasna Hamzi
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Nour Al Thibani
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Sami Alakel
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Faisal Alsharif
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Omar Alsuhaibani
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Omar Alsharif
- Department of Pediatric Hematology/Oncology and Bone Marrow Transplant, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Elborai Y, Alkhayat N, Elyamany G, Alshahrani M, Ibrahim W, Othman M, Hamzi H, Binhassan A, Aljabry MS, Alqawahmed R, Alrusayni Y, Abdulhaleem K, Alsuhaibani O, Alsharif O. Rare tumors in pediatric age group: Single center experience from Saudi Arabia. Rare Tumors 2021; 13:2036361321997331. [PMID: 33708364 PMCID: PMC7907711 DOI: 10.1177/2036361321997331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Accepted: 01/31/2021] [Indexed: 11/17/2022] Open
Abstract
Rare pediatric tumors are heterogeneous group containing a variety of histopathological diseases, they represent approximately 10% of all childhood cancers. These rare tumors had a diversity of histology and clinical behaviors that pose different challenges to the investigators. Exploring different pediatric rare tumors. The data were reviewed, retrospectively, through the medical records of seven rare pediatric diseases between 2012 and 2019. Giant cell fibroblastoma (GCF) presented as painless swelling in the trunk, positive for CD34 with PTEN gene mutation. Neuroglial heterotopic tissue presented in 7 days old girl with facial asymmetry and bulging in the oral cavity, maximal de-bulking was done, histopathology was positive for GFAP and S100p. Left side neck mass, surgically excised revealed non-metastatic salivary grand mucoepidermoid carcinoma. Follow up without any chemotherapy or radiotherapy for 5 years with complete remission. Mesenchymal chondrosarcoma (MCS) presented in maxillofacial bones by persistent nasal bleeding, HEY1-NCOA2 fusion gene confirmed the diagnosis. Extra-osseous Ewing sarcoma (EES) presented as rubbery painless swelling in the scalp with fusion transcript involving EWSR1-FL11. Juvenile xanthogranuloma (JXG) presented by butter fly like skin patch in the face with foamy histiocytes in upper dermis with few Touton giant cells, extensive systemic involvement of lung and bone marrow. Metastatic ovarian choriocarcinoma with choriocarcinoma syndrome received induction two different lines of chemotherapy and consolidated with autologous stem cell transplant. Seven pediatric rare tumors, with different aspects of challenges in diagnosis and management, despite the absence of formal protocols and rarity of other center experiences.
Collapse
Affiliation(s)
- Yasser Elborai
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.,Department of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
| | - Nawaf Alkhayat
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Ghaleb Elyamany
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Mohammad Alshahrani
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Walid Ibrahim
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Mohamed Othman
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Hasna Hamzi
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Amal Binhassan
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Mansour S Aljabry
- Pathology department, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - Raniah Alqawahmed
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Yasir Alrusayni
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Khadijah Abdulhaleem
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Omar Alsuhaibani
- Department of Central Military Laboratory and Blood Bank, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| | - Omar Alsharif
- Division of Pediatric Hematology/Oncology, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
| |
Collapse
|
4
|
Choy KW, Kogilavani S, Norshalizah M, Rani S, Aspalilah A, Hamzi H, Farihah HS, Das S. Topographical anatomy of the profunda femoris artery and the femoral nerve: normal and abnormal relationships. Clin Ter 2014; 164:17-9. [PMID: 23455736 DOI: 10.7417/t.2013.1504] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND AND OBJECTIVE Femoral nerve (FN) is the largest branch of lumbar plexus. It lies lateral to femoral artery (FA) and it is located outside the femoral sheath. Profunda femoris artery (PFA) is a branch of the FA. The present study aimed to observe the topographical anatomy and relationship of the PFA and the FN. MATERIALS AND METHODS A total of 12 embalmed cadaveric lower limbs (7 lefts and 5 rights) were taken and the thighs were dissected in detail. The relationship of PFA and FN were observed. Appropriate measurements were taken and the specimens were photographed. RESULTS The PFA originated from the FA in all the 12 specimens (100%). In 10 specimens (83.3%), the PFA was found to originate lateral to the FA while in 2 specimens, the origin of PFA was posterior to the FA (16.7%). The PFA originated from the FA at a distance of 6.5 + 1.5 cm with regard to the midinguinal point. All FN were found to lie outside the femoral sheaths. Out of the 12 specimens, only 2 specimens (16.7%) exhibited the FN to lie posterior to the PFA, while in 10 specimens (83.3%), the FN was found to lie anterior to the PFA. CONCLUSION Prior anatomical knowledge of structures in the anterior compartment of thigh may be helpful for surgeons performing nerve block, cannulation and catheterization. Knowledge of abnormal anatomy of the FN and PFA is important in order to prevent any inadvertent injury to the PFA or FN.
Collapse
Affiliation(s)
- K W Choy
- Department of Anatomy, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
| | | | | | | | | | | | | | | |
Collapse
|